Philders Group International Inc.’s Research and Development (R&D) division works with companies to enhance new technology they have invented or emerging technology that they would like to use that may positively impact the health of a population as well as sustainability for their company as it pertains to Infection Control. Our unique team of experts provides objective research and investigation for efficacy, positioning, and “take-it-to-market” enhancement and strategy.
Companies that enlist the help of our R&D division can expect thorough examination of specific technology’s viability for their desired area and how best to implement it into practice. This means that our clients walk away with not only summaries of review for application of the technology but a uniquely-developed, optimized marketing strategy for enhancement in the health sector as well.
Client Testimonial:
“I recently reached out to Marlene Linders and the Philders Group Research and Development for a review on a White Paper I recently conducted on Deactivating Mycotoxin Contamination within a closed air conditioning system.
The outcome of the review was most favorable, with the review coinciding in parallel with the White Paper’s conclusion. The impact on my business has been phenomenal, with increased inquiries and the addition of work.
The experience working with Marlene and the Philders Group has been incredibly seamless and professional; they far exceeded my expectation.
I thoroughly recommend and endorse Marlene and the Philders Group; their impact on my business is incredibly positive.”
Mark Quigley, Managing Member
BioRisk Decontamination & Restoration
Does your company have technology related to Infection Control that you need to be examined for market viability? Contact us to get started.
